Macfarlan Smith Limited NDCs and Package Codes
This page lists NDC package records associated with labeler code 12707 (Macfarlan Smith Limited) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
19
Package NDCs
4
Products
4
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Apomorphine Hydrochloride 1 g/g POWDER | 12707-0031-01 | — | On market | View → |
| Buprenorphine 100 g/100g POWDER | 12707-0036-01 | — | On market | View → |
| Buprenorphine Hydrochloride 1 g/g POWDER | 12707-0035-01 | — | On market | View → |
| Naloxone Hydrochloride Dihydrate 100 g/100g POWDER | 12707-0037-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.